Advertisement
Mayo Clinic Proceedings Home

Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer: A Meta-analysis

      OBJECTIVE

      To perform a meta-analysis of case-control studies that addressed whether prior oral contraceptive (OC) use is associated with premenopausal breast cancer.

      METHODS

      We searched the MEDLINE and PubMed databases and bibliography reviews to identify case-control studies of OCs and premenopausal breast cancer published in or after 1980. Search terms used included breast neoplasms, oral contraceptives, contraceptive agents, and case-control studies. Studies reported in all languages were included. Thirty-four studies were identified that met inclusion criteria. Two reviewers extracted data from original research articles or additional data provided by study authors. We used the DerSimonian-Laird method to compute pooled odds ratios (ORs) and confidence intervals (CIs) and the Mantel-Haenszel test to assess association between OC use and cancer.

      RESULTS

      Use of OCs was associated with an increased risk of premenopausal breast cancer in general (OR, 1.19; 95% CI, 1.09-1.29) and across various patterns of OC use. Among studies that provided data on nulliparous and parous women separately, OC use was associated with breast cancer risk in both parous (OR, 1.29; 95% CI, 1.20-1.40) and nulliparous (OR, 1.24; 95% CI, 0.92-1.67) women. Longer duration of use did not substantially alter risk in nulliparous women (OR, 1.29; 95% CI, 0.85-1.96). Among parous women, the association was stronger when OCs were used before first full-term pregnancy (FFTP) (OR, 1.44; 95% CI, 1.28-1.62) than after FFTP (OR, 1.15; 95% CI, 1.06-1.26). The association between OC use and breast cancer risk was greatest for parous women who used OCs 4 or more years before FFTP (OR, 1.52; 95% CI, 1.26-1.82).

      CONCLUSION

      Use of OCs is associated with an increased risk of premenopausal breast cancer, especially with use before FFTP in parous women.
      CI (confidence interval), FFTP (first full-term pregnancy), OC (oral contraceptive), OR (odds ratio)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Jemal A
        • Murray T
        • Ward E
        • et al.
        Cancer statistics, 2005 [published correction appears in CA Cancer J Clin. 2005;55:259].
        CA Cancer J Clin. 2005; 55: 10-30
      1. Breast cancer facts and figures 2003-2004. Atlanta (GA): American Cancer Society; c2003.
        (Accessed September 5, 2006.)
      2. Ries LAG Eisner MP Kosary CL SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda (MD)2002 (Accessed September 5, 2006.)
        • Newcomb PA
        • Storer BE
        • Longnecker MP
        • et al.
        Lactation and a reduced risk of premenopausal breast cancer.
        N Engl J Med. 1994; 330: 81-87
        • McTiernan A
        • Thomas DB
        Evidence for a protective effect of lactation on risk of breast cancer in young women: results from a case-control study.
        Am J Epidemiol. 1986; 124: 353-358
        • Lowe CR
        • MacMahon B
        Breast cancer and reproductive history of women in South Wales.
        Lancet. 1970; 1: 153-156
        • Mirra AP
        • Cole P
        • MacMahon B
        Breast cancer in an area of high parity: Sao Paulo, Brazil.
        Cancer Res. 1971; 31: 77-83
        • Chlebowski RT
        • Hendrix SL
        • Langer RD
        • WHI Investigators
        • et al.
        Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
        JAMA. 2003; 289: 3243-3253
        • World Health Organization International Agency for Research on Cancer
        IARC monographs programme finds combined estrogen-progestogen contraceptives and menopausal therapy are carcinogenic to humans [press release 167].
        (Accessed September 1, 2006.)
        • Romieu I
        • Berlin JA
        • Colditz G
        Oral contraceptives and breast cancer: review and meta-analysis.
        Cancer. 1990; 66: 2253-2263
        • Collaborative Group on Hormonal Factors in Breast Cancer
        Breast cancer and hormonal contraceptives: further results.
        Contraception. 1996; 54: 1S-106S
        • Thomas DB
        Oral contraceptives and breast cancer: review of the epidemiologic literature.
        Contraception. 1991; 43: 597-642
        • Hawley W
        • Nuovo J
        • DeNeef CP
        • Carter P
        Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports.
        J Am Board Fam Pract. 1993; 6: 123-135
        • Delgado-Rodriguez M
        • Sillero-Arenas M
        • Rodriguez-Contreras R
        • Lopez Gigosos R
        • Galvez Vargas R
        Oral contraceptives and breast cancer: a meta-analysis.
        Rev Epidemiol Sante Publique. 1991; 39: 165-181
        • Rushton L
        • Jones DR
        Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use.
        Br J Obstet Gynaecol. 1992; 99: 239-246
        • Russo J
        • Hu YF
        • Silva ID
        • Russo IH
        Cancer risk related to mammary gland structure and development.
        Microsc Res Tech. 2001; 52: 204-223
        • Kelsey JL
        A review of the epidemiology of human breast cancer.
        Epidemiol Rev. 1979; 1: 74-109
        • Helmrich SP
        • Shapiro S
        • Rosenberg L
        • et al.
        Risk factors for breast cancer.
        Am J Epidemiol. 1983; 117: 35-45
        • Ross RK
        • Paganini-Hill A
        • Gerkins VR
        • et al.
        A case-control study of menopausal estrogen therapy and breast cancer.
        JAMA. 1980; 243: 1635-1639
        • Stanford JL
        • Brinton LA
        • Hoover RN
        Oral contraceptives and breast cancer: results from an expanded case-control study.
        Br J Cancer. 1989; 60: 375-381
        • Ursin G
        • Aragaki CC
        • Paganini-Hill A
        • Siemiatycki J
        • Thompson WD
        • Haile RW
        Oral contraceptives and premenopausal bilateral breast cancer: a case-control study.
        Epidemiology. 1992; 3: 414-419
        • Pike MC
        • Henderson BE
        • Krailo MD
        • Duke A
        • Roy S
        Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
        Lancet. 1983; 2: 926-930
        • Morabia A
        • Szklo M
        • Stewart W
        • Schuman L
        • Thomas DB
        Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls.
        Prev Med. 1993; 22: 178-186
        • Vessey M
        • Baron J
        • Doll R
        • McPherson K
        • Yeates D
        Oral contraceptives and breast cancer: final report of an epidemiological study.
        Br J Cancer. 1983; 47: 455-462
        • Schildkraut JM
        • Hulka BS
        • Wilkinson WE
        Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
        Obstet Gynecol. 1990; 76: 395-402
        • Yang CP
        • Daling JR
        • Band PR
        • Gallagher RP
        • White E
        • Weiss NS
        Noncontraceptive hormone use and risk of breast cancer.
        Cancer Causes Control. 1992; 3: 475-479
        • Rossing MA
        • Stanford JL
        • Weiss NS
        • Habel LA
        Oral contraceptive use and risk of breast cancer in middle-aged women.
        Am J Epidemiol. 1996; 144: 161-164
        • Tavani A
        • Negri E
        • Franceschi S
        • Parazzini F
        • La Vecchia C
        Oral contraceptives and breast cancer in northern Italy: final report from a case-control study.
        Br J Cancer. 1993; 68: 568-571
        • La Vecchia C
        • Negri E
        • Franceschi S
        • et al.
        Oral contraceptives and breast cancer: a cooperative Italian study.
        Int J Cancer. 1995; 60: 163-167
        • Tavani A
        • Gallus S
        • La Vecchia C
        • et al.
        Risk factors for breast cancer in women under 40 years.
        Eur J Cancer. 1999; 35: 1361-1367
        • Sanderson M
        • Shu XO
        • Jin F
        • et al.
        Abortion history and breast cancer risk: results from the Shanghai Breast Cancer Study.
        Int J Cancer. 2001; 92: 899-905
        • Hislop TG
        • Coldman AJ
        • Elwood JM
        • Brauer G
        • Kan L
        Childhood and recent eating patterns and risk of breast cancer.
        Cancer Detect Prev. 1986; 9: 47-58
        • Rohan TE
        • McMichael AJ
        Oral contraceptive agents and breast cancer: a population-based case-control study.
        Med J Aust. 1988; 149: 520-526
        • Segala C
        • Gerber M
        • Richardson S
        The pattern of risk factors for breast cancer in a southern France population: interest for a stratified analysis by age at diagnosis.
        Br J Cancer. 1991; 64: 919-925
        • Siskind V
        • Schofield F
        • Rice D
        • Bain C
        Breast cancer and breastfeeding: results from an Australian case-control study.
        Am J Epidemiol. 1989; 130: 229-236
        • Bustan MN
        • Coker AL
        • Addy CL
        • Macera CA
        • Greene F
        • Sampoerno D
        Oral contraceptive use and breast cancer in Indonesia.
        Contraception. 1993; 47: 241-249
        • Ngelangel C
        • Lacaya LB
        • Cordero C
        • Laudico AV
        Risk factors for breast cancer among Filipino women.
        Philipp J Intern Med. 1994; 32: 231-236
        • Ravnihar B
        • Primic Zakelj M
        • Kosmelj K
        • Stare J
        A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.
        Neoplasma. 1988; 35: 109-121
        • Talamini R
        • La Vecchia C
        • Franceschi S
        • et al.
        Reproductive and hormonal factors and breast cancer in a Northern Italian population.
        Int J Epidemiol. 1985; 14: 70-74
        • Wang QS
        • Ross RK
        • Yu MC
        • Ning JP
        • Henderson BE
        • Kimm HT
        A case-control study of breast cancer in Tianjin, China.
        Cancer Epidemiol Biomarkers Prev. 1992; 1: 435-439
        • Ellery C
        • MacLennan R
        • Berry G
        • Shearman RP
        A case-control study of breast cancer in relation to the use of steroid contraceptive agents.
        Med J Aust. 1986; 144: 173-176
        • Ursin G
        • Ross RK
        • Sullivan-Halley J
        • Hanisch R
        • Henderson B
        • Bernstein L
        Use of oral contraceptives and risk of breast cancer in young women.
        Breast Cancer Res Treat. 1998; 50: 175-184
        • Brinton LA
        • Daling JR
        • Liff JM
        • et al.
        Oral contraceptives and breast cancer risk among younger women.
        J Natl Cancer Inst. 1995; 87: 827-835
        • Chie WC
        • Li CY
        • Huang CS
        • Chang KJ
        • Yen ML
        • Lin RS
        Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
        Int J Cancer. 1998; 77: 219-223
        • UK National Case-Control Study Group
        Oral contraceptive use and breast cancer risk in young women.
        Lancet. 1989; 1: 973-982
        • Clavel F
        • Andrieu N
        • Gairard B
        • et al.
        Oral contraceptives and breast cancer: a French case-control study.
        Int J Epidemiol. 1991; 20: 32-38
        • Ewertz M
        Oral contraceptives and breast cancer risk in Denmark.
        Eur J Cancer. 1992; 28A: 1176-1181
        • Gomes AL
        • Guimaraes MD
        • Gomes CC
        • Chaves IG
        • Gobbi H
        • Camargos AF
        A case-control study of risk factors for breast cancer in Brazil, 1978-1987.
        Int J Epidemiol. 1995; 24: 292-299
        • Le MG
        • Bachelot A
        • Doyen F
        • Kramar A
        A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study [in French].
        Contracept Fertil Sex (Paris). 1985; 13: 553-558
        • Lee NC
        • Rosero-Bixby L
        • Oberle MW
        • Grimaldo C
        • Whatley AS
        • Rovira EZ
        A case-control study of breast cancer and hormonal contraception in Costa Rica.
        J Natl Cancer Inst. 1987; 79: 1247-1254
        • Lee HP
        • Gourley L
        • Duffy SW
        • Esteve J
        • Lee J
        • Day NE
        Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore.
        Cancer Causes Control. 1992; 3: 313-322
        • Marchbanks PA
        • McDonald JA
        • Wilson HG
        • et al.
        Oral contraceptives and the risk of breast cancer.
        N Engl J Med. 2002; 346: 2025-2032
        • Marcus PM
        • Baird DD
        • Millikan RC
        • Moorman PG
        • Qaqish B
        • Newman B
        Adolescent reproductive events and subsequent breast cancer risk.
        Am J Public Health. 1999; 89: 1244-1247
        • Marubini E
        • Decarli A
        • Costa A
        • et al.
        The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer: results of a case-control study.
        Cancer. 1988; 61: 173-180
        • McCredie MR
        • Dite GS
        • Giles GG
        • Hopper JL
        Breast cancer in Australian women under the age of 40.
        Cancer Causes Control. 1998; 9: 189-198
        • McPherson K
        • Vessey MP
        • Neil A
        • Doll R
        • Jones L
        • Roberts M
        Early oral contraceptive use and breast cancer: results of another case-control study.
        Br J Cancer. 1987; 56: 653-660
        • Meirik O
        • Lund E
        • Adami HO
        • Bergstrom R
        • Christoffersen T
        • Bergsjo P
        Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway.
        Lancet. 1986; 2: 650-654
        • Moorman PG
        • Millikan RC
        • Newman B
        Oral contraceptives and breast cancer among African-American women and white women.
        J Natl Med Assoc. 2001; 93: 329-334
        • Newcomb PA
        • Longnecker MP
        • Storer BE
        • et al.
        Recent oral contraceptive use and risk of breast cancer (United States).
        Cancer Causes Control. 1996; 7: 525-532
        • WHO Collaborative Study of Neoplasia and Steroid Contraceptives
        Breast cancer and combined oral contraceptives: results from a multinational study.
        Br J Cancer. 1990; 61: 110-119
        • Olsson H
        • Moller TR
        • Ranstam J
        Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
        J Natl Cancer Inst. 1989; 81: 1000-1004
        • Palmer JR
        • Rosenberg L
        • Rao RS
        • et al.
        Oral contraceptive use and breast cancer risk among African-American women.
        Cancer Causes Control. 1995; 6: 321-331
        • Paul C
        • Skegg DC
        • Spears GF
        Oral contraceptives and risk of breast cancer.
        Int J Cancer. 1990; 46: 366-373
        • Primic-Zakelj M
        • Evstifeeva T
        • Ravnihar B
        • Boyle P
        Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54.
        Int J Cancer. 1995; 62: 414-420
        • Rookus MA
        • van Leeuwen FE
        • Netherlands Oral Contraceptives and Breast Cancer Study Group
        Oral contraceptives and risk of breast cancer in women aged 20-54 years.
        Lancet. 1994; 344: 844-851
        • Rosenberg L
        • Palmer JR
        • Clarke EA
        • Shapiro S
        A case-control study of the risk of breast cancer in relation to oral contraceptive use.
        Am J Epidemiol. 1992; 136: 1437-1444
        • Shapiro S
        • Rosenberg L
        • Hoffman M
        • et al.
        Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives [published correction appears in Am J Epidemiol. 2000;151:1134].
        Am J Epidemiol. 2000; 151: 396-403
        • Tessaro S
        • Beria JU
        • Tomasi E
        • Barros AJ
        Oral contraceptive and breast cancer: a case-control study [in Portuguese].
        Rev Saude Publica. 2001; 35: 32-38
        • Traina A
        • Cusimano R
        • Liquori M
        • et al.
        Oral contraceptive use and breast cancer risk in areas with different incidence: a case-control study among young women.
        Ann N Y Acad Sci. 1996; 784: 564-569
        • Ursin G
        • Wu AH
        • Hoover RN
        • et al.
        Breast cancer and oral contraceptive use in Asian-American women.
        Am J Epidemiol. 1999; 150: 561-567
        • Weinstein AL
        • Mahoney MC
        • Nasca PC
        • Leske MC
        • Varma AO
        Breast cancer risk and oral contraceptive use: results from a large case-control study.
        Epidemiology. 1991; 2: 353-358
        • Wingo PA
        • Lee NC
        • Ory HW
        • Beral V
        • Peterson HB
        • Rhodes P
        Age-specific differences in the relationship between oral contraceptive use and breast cancer.
        Cancer. 1993; 71: 1506-1517
        • White E
        • Malone KE
        • Weiss NS
        • Daling JR
        Breast cancer among young U.S. women in relation to oral contraceptive use.
        J Natl Cancer Inst. 1994; 86: 505-514
        • Yuan JM
        • Yu MC
        • Ross RK
        • Gao YT
        • Henderson BE
        Risk factors for breast cancer in Chinese women in Shanghai.
        Cancer Res. 1988; 48: 1949-1953
        • Rosenberg L
        • Palmer JR
        • Rao RS
        • et al.
        Case-control study of oral contraceptive use and risk of breast cancer.
        Am J Epidemiol. 1996; 143: 25-37
        • The Centers for Disease Control Cancer and Steroid Hormone Study
        Long-term oral contraceptive use and the risk of breast cancer.
        JAMA. 1983; 249: 1591-1595
        • The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
        Oral-contraceptive use and the risk of breast cancer.
        N Engl J Med. 1986; 315: 405-411
        • Stadel BV
        • Lai SH
        • Schlesselman JJ
        • Murray P
        Oral contraceptives and premenopausal breast cancer in nulliparous women.
        Contraception. 1988; 38: 287-299
        • Mayberry RM
        Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.
        Ann Epidemiol. 1994; 4: 205-213
        • Miller DR
        • Rosenberg L
        • Kaufman DW
        • Stolley P
        • Warshauer ME
        • Shapiro S
        Breast cancer before age 45 and oral contraceptive use: new findings.
        Am J Epidemiol. 1989; 129: 269-280
        • Lund E
        • Meirik O
        • Adami HO
        • Bergstrom R
        • Christoffersen T
        • Bergsjo P
        Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of use.
        Int J Epidemiol. 1989; 18: 527-532
        • DerSimonian R
        • Laird N
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Collaborative Group on Hormonal Factors in Breast Cancer
        Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
        Lancet. 1996; 347: 1713-1727
        • Althuis MD
        • Brogan DR
        • Coates RJ
        • et al.
        Hormonal content and potency of oral contraceptives and breast cancer risk among young women.
        Br J Cancer. 2003; 88: 50-57
        • Nomura AM
        • Kolonel LN
        • Hirohata T
        • Lee J
        The association of replacement estrogens with breast cancer.
        Int J Cancer. 1986; 37: 49-53
        • McGregor H
        • Land CE
        • Choi K
        • et al.
        Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.
        J Natl Cancer Inst. 1977; 59: 799-811
        • Kirschstein RL
        • Rabson AS
        • Rusten GW
        Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: a preliminary report.
        J Natl Cancer Inst. 1972; 48: 551-556
        • Geil RG
        • Lamar JK
        FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.
        J Toxicol Environ Health. 1977; 3: 179-193
        • Shubik P
        Oral contraceptives and breast cancer: laboratory evidence.
        IARC Sci Publ. 1985; : 33-35
        • Lanari C
        • Molinolo AA
        • Pasqualini CD
        Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice.
        Cancer Lett. 1986; 33: 215-223
        • Welsch CW
        • Adams C
        • Lambrecht LK
        • Hassett CC
        • Brooks CL
        17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
        Br J Cancer. 1977; 35: 322-328
        • Kahn RH
        • Baker BL
        Effect of long-term treatment with norethynodrel on A-J and C3H-HeJ mice.
        Endocrinology. 1969; 84: 661-668
        • Anderson TJ
        • Battersby S
        • King RJ
        • McPherson K
        • Going JJ
        Oral contraceptive use influences resting breast proliferation.
        Hum Pathol. 1989; 20: 1139-1144
        • Preston-Martin S
        • Pike MC
        • Ross RK
        • Jones PA
        • Henderson BE
        Increased cell division as a cause of human cancer.
        Cancer Res. 1990; 50: 7415-7421
        • Ames BN
        • Gold LS
        Too many rodent carcinogens: mitogenesis increases mutagenesis.
        Science. 1990; 249: 970-971
        • Cohen SM
        • Ellwein LB
        Cell proliferation in carcinogenesis.
        Science. 1990; 249: 1007-1011
        • Larimore WL
        • Stanford JB
        Postfertilization effects of oral contraceptives and their relationship to informed consent.
        Arch Fam Med. 2000; 9: 126-133
        • Norman RJ
        • McLoughlin JW
        • Borthwick GM
        • et al.
        Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: relationship to gonadotropin and steroid profiles.
        Fertil Steril. 1993; 59: 130-137
        • Stewart DR
        • Overstreet JW
        • Nakajima ST
        • Lasley BL
        Enhanced ovarian steroid secretion before implantation in early human pregnancy.
        J Clin Endocrinol Metab. 1993; 76: 1470-1476
      3. Another look at the pill and breast cancer.
        Lancet. 1985; 2: 985-987
        • Hulka BS
        Oral contraceptives: the good news.
        JAMA. 1983; 249: 1624-1625
        • Olsson H
        • Borg A
        • Ferno M
        • Moller TR
        • Ranstam J
        Early oral contraceptive use and premenopausal breast cancer: a review of studies performed in southern Sweden.
        Cancer Detect Prev. 1991; 15: 265-271
        • Malone KE
        • Daling JR
        • Weiss NS
        Oral contraceptives in relation to breast cancer.
        Epidemiol Rev. 1993; 15: 80-97
        • Colton T
        • Greenberg ER
        • Noller K
        • et al.
        Breast cancer in mothers prescribed diethylstilbestrol in pregnancy: further follow-up.
        JAMA. 1993; 269: 2096-2100
        • Olsson H
        • Ranstam J
        • Baldetorp B
        • et al.
        Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.
        Cancer. 1991; 67: 1285-1290
        • Olsson H
        • Borg A
        • Ferno M
        • Ranstam J
        • Sigurdsson H
        Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.
        J Natl Cancer Inst. 1991; 83: 1483-1487
        • Ranstam J
        • Olsson H
        • Garne JP
        • Aspegren K
        • Janzon L
        Survival in breast cancer and age at start of oral contraceptive usage.
        Anticancer Res. 1991; 11: 2043-2046
        • Gammon MD
        • Hibshoosh H
        • Terry MB
        • et al.
        Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
        Cancer Epidemiol Biomarkers Prev. 1999; 8: 413-419
        • Rosenberg MJ
        • Waugh MS
        Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.
        Am J Obstet Gynecol. 1998; 179: 577-582
        • Potter LS
        Oral contraceptive compliance and its role in the effectiveness of the method.
        in: Cramer JA Spilker B Patient Compliance In Medical Practice and Clinical Trials. Raven Press, New York1991: 195-207
        • Balassone ML
        Risk of contraceptive discontinuation among adolescents.
        J Adolesc Health Care. 1989; 10: 527-533
        • Nischan P
        • Ebeling K
        • Thomas DB
        • Hirsch U
        Comparison of recalled and validated oral contraceptive histories.
        Am J Epidemiol. 1993; 138: 697-703
        • Alexander FE
        • Roberts MM
        • Huggins A
        Risk factors for breast cancer with applications to selection for the prevalence screen.
        J Epidemiol Community Health. 1987; 41: 101-106
        • Beral V
        • Hermon C
        • Kay C
        • Hannaford P
        • Darby S
        • Reeves G
        Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.
        BMJ. 1999; 318: 96-100
        • Calle EE
        • Martin LM
        • Thun MJ
        • Miracle HL
        • Heath Jr, CW
        Family history, age, and risk of fatal breast cancer.
        Am J Epidemiol. 1993; 138: 675-681
        • Dumeaux V
        • Alsaker E
        • Lund E
        Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.
        Int J Cancer. 2003; 105: 844-850
        • Grabrick DM
        • Hartmann LC
        • Cerhan JR
        • et al.
        Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
        JAMA. 2000; 284: 1791-1798
        • Hankinson SE
        • Colditz GA
        • Manson JE
        • et al.
        A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States).
        Cancer Causes Control. 1997; 8: 65-72
        • Hiatt RA
        • Bawol R
        • Friedman GD
        • Hoover R
        Exogenous estrogen and breast cancer after bilateral oophorectomy.
        Cancer. 1984; 54: 139-144
        • Kay CR
        • Hannaford PC
        Breast cancer and the pill: a further report from the Royal College of General Practitioners' oral contraception study.
        Br J Cancer. 1988; 58: 675-680
        • Kumle M
        • Weiderpass E
        • Braaten T
        • Persson I
        • Adami HO
        • Lund E
        Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
        Cancer Epidemiol Biomarkers Prev. 2002; 11: 1375-1381
        • Miller AB
        • Baines CJ
        • To T
        • Wall C
        Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published correction appears in CMAJ. 1993;148:718].
        CMAJ. 1992; 147: 1459-1476
        • Mills PK
        • Beeson WL
        • Phillips RL
        • Fraser GE
        Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists.
        Cancer. 1989; 64: 591-597
        • Schuurman AG
        • van den Brandt PA
        • Goldbohm RA
        Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study.
        Cancer Causes Control. 1995; 6: 416-424
        • Tomasson H
        • Tomasson K
        Oral contraceptives and risk of breast cancer: a historical prospective case-control study.
        Acta Obstet Gynecol Scand. 1996; 75: 157-161
        • Trapido EJ
        A prospective cohort study of oral contraceptives and breast cancer.
        J Natl Cancer Inst. 1981; 67: 1011-1015
        • Tryggvadottir L
        • Tulinius H
        • Gudmundsdottir GB
        Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year.
        Br J Cancer. 1997; 75: 139-143
        • Van Hoften C
        • Burger H
        • Peeters PH
        • Grobbee DE
        • Van Noord PA
        • Leufkens HG
        Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: the DOM cohort.
        Int J Cancer. 2000; 87: 591-594
        • Vessey MP
        • McPherson K
        • Villard-Mackintosh L
        • Yeates D
        Oral contraceptives and breast cancer: latest findings in a large cohort study.
        Br J Cancer. 1989; 59: 613-617
        • Dickey RP
        • Stone SC
        Progestational potency of oral contraceptives.
        Obstet Gynecol. 1976; 47: 106-112
        • Staffa JA
        • Newschaffer CJ
        • Jones JK
        • Miller V
        Progestins and breast cancer: an epidemiologic review.
        Fertil Steril. 1992; 57: 473-491
        • Skegg DC
        • Noonan EA
        • Paul C
        • Spears GF
        • Meirik O
        • Thomas DB
        Depot medroxyprogesterone acetate and breast cancer: a pooled analysis of the World Health Organization and New Zealand studies.
        JAMA. 1995; 273: 799-804
        • Anderson GL
        • Limacher M
        • Assaf AR
        • Women's Health Initiative Steering Committee
        • et al.
        Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
        JAMA. 2004; 291: 1701-1712
        • Tyrer L
        Introduction of the pill and its impact.
        Contraception. 1999; 59: 11S-16S

      Linked Article

      • Oral Contraceptive Use and Breast Cancer Risk: Current Status
        Mayo Clinic ProceedingsVol. 81Issue 10
        • Preview
          One might have thought that the issue of whether oral contraceptives (OCs) are associated with breast cancer risk would have been settled by now, given that these agents were introduced in the early 1960s and more than 60 case-control and 10 cohort studies, several meta-analyses,1–4 a very large pooled analysis,5 and a major monograph6 have addressed this issue. On the basis of the accumulated data, the International Agency for Research on Cancer (IARC) classified oral estrogen-progestogen contraceptives as carcinogenic to humans (group 1 carcinogen) in 2005, which is a higher classification than the 1999 IARC evaluation.
        • Full-Text
        • PDF